News > Glenmark launches country’s first nasal spray for patients

Glenmark launches country’s first nasal spray for patients

National Herald | 09/02/2022 03:10 PM | Click to read full article

Indian pharma major Glenmark Pharmaceuticals Limited and Canadian pharmaceutical company SaNOtize Research & Development Corp, on Wednesday announced the launch of nasal spray to treat adult Covid-19 patients.

According to Glenmark, the nitric oxide nasal spray (NONS) will be sold under the brand FabiSpray in India for the treatment of adult patients with Covid-19 who have a high risk of progression of the disease.